PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Division of Cardiovascular Medicine, Michigan Medicine, Ann Arbor, MI, USA.\', \'Department of Internal Medicine, Division of Cardiovascular Medicine, Michigan Medicine, Ann Arbor, MI, USA. Electronic address: nadiaraz@med.umich.edu.\', \'Department of Cardiac Surgery, Michigan Medicine, Ann Arbor, MI, USA.\', \'Department of Internal Medicine, Division of Cardiovascular Medicine, Michigan Medicine, Ann Arbor, MI, USA; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0014-2999(21)00141-210.1016/j.ejphar.2021.173988
?:doi
?:hasPublicationType
?:journal
  • European journal of pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33667455
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.057
?:rankingScore_hIndex
  • 161
is ?:relation_isRelatedTo_publication of
?:title
  • Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33667455>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33667455>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all